Literature DB >> 2865270

Agonist-induced redistribution of beta-adrenergic receptors on intact human mononuclear leukocytes: redistributed receptors are nonfunctional.

A De Blasi, M Lipartiti, H J Motulsky, P A Insel, M Fratelli.   

Abstract

Incubation of human mononuclear leukocytes (MLN) with isoproterenol rapidly desensitizes beta-adrenergic receptors, i.e. isoproterenol-stimulated cAMP accumulation decreases. This desensitization is accompanied by a redistribution of the receptor into a cellular environment to which hydrophilic compounds have limited access. We found that the total number of beta-receptors [defined as binding of [3H]dihydroalprenolol (DHA) inhibited by 1 microM propranolol] was unchanged in the desensitized MNL. In control MNL, virtually all DHA binding was inhibited by 1 microM CGP-12177, suggesting that all of these receptors are on the cell surface, whereas in desensitized cells, only 33 +/- 2% (mean +/- SEM) of the DHA binding was inhibited by CGP-12177. We quantitated the sequestered receptors by subtracting the number of surface receptors from the total number of receptors. The sequestered receptors were homogeneous, with an affinity for DHA identical to that of surface receptors (Kd, 0.66 +/- 0.12 vs. 0.62 +/- 0.08 nM). The time courses of desensitization and sequestration were identical. The functional status of the sequestered receptors was assessed using the agonist zinterol, which (unlike catecholamines) is quite hydrophobic. Zinterol competed for DHA binding to both sequestered and surface receptors, whereas isoproterenol only competed for binding to the surface receptors. However, cAMP accumulation in desensitized MNL was reduced to the same extent regardless of whether isoproterenol or zinterol was used as the agonist. These results demonstrate that desensitization of intact cells to beta-agonists cannot be attributed to limited accessibility of the sequestered receptors to catecholamines, but, rather, that the sequestered receptors are not functionally coupled to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865270     DOI: 10.1210/jcem-61-6-1081

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  In vivo regulation of beta-adrenergic receptors on mononuclear leukocytes and heart. Assessment of receptor compartmentation after agonist infusion and acute aortic constriction in guinea pigs.

Authors:  A S Maisel; M G Ziegler; S Carter; P A Insel; H J Motulsky
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Relation between beta-adrenergic receptor density and lymphocyte proliferation associates with acute stress.

Authors:  L Redwine; F Jenkins; A Baum
Journal:  Int J Behav Med       Date:  1996

3.  Beta 2-adrenoceptor up-regulation in relation to cAMP production in human lymphocytes after physical exercise.

Authors:  S J Graafsma; L J van Tits; P H Willems; M P Hectors; J F Rodrigues de Miranda; J J De Pont; T Thien
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

4.  Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex.

Authors:  Dennis W McGraw; Kathryn A Mihlbachler; Mary Rose Schwarb; Fahema F Rahman; Kersten M Small; Khalid F Almoosa; Stephen B Liggett
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  Human platelet beta 2-adrenoceptors: agonist-induced internalisation and down-regulation in intact cells.

Authors:  N Cook; S R Nahorski; D B Barnett
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

6.  Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2.

Authors:  A De Blasi; G Parruti; M Sallese
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.